Want to see NVCR full AI Analyst Report?
NovoCure (NVCR) Income Statement
NovoCure Income Statement
Last quarter (Q3 2026), NovoCure's total revenue was $193.40M, an increase of 15.67% from the same quarter last year. In Q3, NovoCure's net income was $-10.44M. See NovoCure’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 655.35M | $ 605.22M | $ 509.34M | $ 537.84M | $ 535.03M | |
| $ 488.47M | $ 468.04M | $ 381.06M | $ 422.97M | $ 420.15M | |
| $ 642.27M | $ 638.53M | $ 614.67M | $ 512.50M | $ 464.49M | |
| Depreciation and Amortization | $ 14.65M | $ 11.23M | $ 10.97M | $ 10.62M | $ 10.25M |
| $ -121.60M | $ -109.58M | $ -177.45M | $ -67.89M | $ -38.38M | |
| $ -153.80M | $ -170.50M | $ -232.87M | $ -89.52M | $ -44.33M | |
| $ 17.55M | $ 39.33M | $ 41.13M | $ 7.68M | $ -7.74M | |
| $ -136.25M | $ -131.16M | $ -191.74M | $ -81.85M | $ -52.08M | |
| $ -136.23M | $ -168.63M | $ -207.04M | $ -92.53M | $ -58.35M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.22 | $ -1.56 | $ -1.95 | $ -0.88 | $ -0.56 |
| Diluted EPS | $ -1.22 | $ -1.56 | $ -1.95 | $ -0.88 | $ -0.56 |
| Weighted Average Shares Outstanding | 111.47M | 107.83M | 106.39M | 104.66M | 103.43M |
| Weighted Average Shares Outstanding (Diluted) | 111.47M | 107.83M | 106.39M | 104.66M | 103.43M |
Currency in USD
